Oral corticosteroid (OCS) burden and healthcare resource utilization (HCRU) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who did or did not undergo functional endoscopic sinonasal surgery (FESS) in US real-world practice
Asif Khan(National Institute for Health and Care Research), Scott D. Nash(Regeneron (United States)), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Juby A. Jacob‐Nara(Morristown Medical Center), Anju T. Peters(Northwestern University), Sietze Reitsma(Advisory Board Company (United States)), Peter H. Hwang(Stanford University), Danielle L. Isaman(Aetion (United States)), Stella Lee(Dartmouth–Hitchcock Medical Center)
Cited by 0
Related Papers
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
|International Forum of Allergy & Rhinology|2018|549
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
|Journal of Allergy and Clinical Immunology|2019|137
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
|Clinical and Translational Allergy|2019|131
Development of Sinonasal Outcome Test (SNOT‐22) Domains in Chronic Rhinosinusitis With Nasal Polyps
|The Laryngoscope|2021|96